Neuregulin-1, a potential therapeutic target for cardiac repair

45Citations
Citations of this article
47Readers
Mendeley users who have this article in their library.

Abstract

NRG1 (Neuregulin-1) is an effective cardiomyocyte proliferator, secreted and released by endothelial vascular cells, and affects the cardiovascular system. It plays a major role in heart growth, proliferation, differentiation, apoptosis, and other cardiovascular processes. Numerous experiments have shown that NRG1 can repair the heart in the pathophysiology of atherosclerosis, myocardial infarction, ischemia reperfusion, heart failure, cardiomyopathy and other cardiovascular diseases. NRG1 can connect related signaling pathways through the NRG1/ErbB pathway, which form signal cascades to improve the myocardial microenvironment, such as regulating cardiac inflammation, oxidative stress, necrotic apoptosis. Here, we summarize recent research advances on the molecular mechanisms of NRG1, elucidate the contribution of NRG1 to cardiovascular disease, discuss therapeutic approaches targeting NRG1 associated with cardiovascular disease, and highlight areas for future research.

Cite

CITATION STYLE

APA

Wang, Y., Wei, J., Zhang, P., Zhang, X., Wang, Y., Chen, W., … Cui, X. (2022, August 31). Neuregulin-1, a potential therapeutic target for cardiac repair. Frontiers in Pharmacology. Frontiers Media S.A. https://doi.org/10.3389/fphar.2022.945206

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free